SEC Comment Letter for Legend Biotech Corp (LEGN) (CIK 0001801198) (LEGN) — Sep 15, 2023

Legend Biotech Corp (LEGN) (CIK 0001801198)
Date: Sept. 15, 2023 · CIK: 0001801198 · Accession: 0000000000-23-010246

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-39307

Date

September 15, 2023

Author

Ying Huang, Ph.D.

Form

UPLOAD

Company

Legend Biotech Corp (LEGN) (CIK 0001801198)

Letter

United States securities and exchange commission logo September 15, 2023 Ying Huang, Ph.D. Chief Executive Officer Legend Biotech Corp 2101 Cottontail Lane Somerset, NJ 08873 Re:Legend Biotech Corp Form 20-F for the Fiscal Year Ended December 31, 2022 File No. 001-39307 Dear Ying Huang: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Disclosure Review Program cc: Mark Ballantyne

Show Raw Text

United States securities and exchange commission logo
September 15, 2023
Ying Huang, Ph.D.
Chief Executive Officer
Legend Biotech Corp
2101 Cottontail Lane
Somerset, NJ 08873
Re:Legend Biotech Corp
Form 20-F for the Fiscal Year Ended December 31, 2022
File No. 001-39307
Dear Ying Huang:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Disclosure Review Program
cc:       Mark Ballantyne

SecProbe.io